Structure-based virtual screening, multi-score docking, and molecular dynamics simulation of novel small molecules targeting the epidermal growth factor receptor for potential management of oral squamous cell carcinoma
The potential therapeutic relevance of structurally novel EGFR-targeting scaffolds in OSCC is suggested and a foundation for future experimental validation through in vitro and in vivo studies is provided.
Results indicate that perimidine-based molecules, particularly Compound 101 and Compound 201, are promising compounds towards the development as EGFR-targeting anticancer drugs; however, further biochemical and cellular target-validation studies are required to confirm direct EGFR inhibition and their therapeutic poten...
M. Gopinadh, Sreehari A. P., S. S et al.· Naunyn-Schmiedeberg's Archiv...· 0 citations
Pr3 has a higher effectiveness in treating liver cancer when compared to the other compounds, emerges as a promising hit candidate for further experimental investigation and Lipinski characteristics and synthetic accessibility coefficient suggest their potential for therapeutic use.
Y. Moukhliss, Y. Koubi, L. Naanaai et al.· Chemistry Africa· 0 citations
ABSTRACT Oestrogen receptor alpha (ERα) is a driver of hormone-dependent breast cancer, yet current therapies are often hindered by drug resistance and adverse effects. In this study, we developed a structure-based virtual screening workflow to identify novel quinoxaline derivatives as computationally prioritized poten...
A. Sharma, D. Kumar, B. Narasimhan et al.· SAR and QSAR in environmenta...· 0 citations
Hypoxia within solid tumors triggers upregulation of carbonic anhydrase IX (CA IX), a key enzyme that maintains pH homeostasis and supports tumor survival, invasion, and therapy resistance. Selective CA IX inhibition is considered a promising anticancer strategy, but current inhibitors often lack isoform selectivity. T...
M. Ali, Monther F. Mahdi· Al Mustansiriyah Journal of...· 0 citations
Breast cancer still ranks to be one of the primary causes of cancer-related death worldwide, underscoring the critical need for innovative targeted treatment agents with enhanced safety and efficacy. The current work examined Thienopyrimidinone-based derivatives as possible EGFR inhibitors for breast cancer treatment u...
Shashikant V. Bhandari, Rutuja R. Napte, S. Patil et al.· Bioorganic chemistry (Print)· 0 citations
Objective: The epidermal growth factor receptor (EGFR) is a clinically established molecular target that plays a key role in the initiation and progression of multiple human cancers. This study aimed to rationally design and evaluate a series of 2-aryl-substituted benzimidazole, benzothiazole, and benzoxazole derivativ...